Andrew J. Muir, MD, MHS, FACP, attended Trinity University in San Antonio, TX for his undergraduate education. He received his medical degree and a master of health sciences degree from Duke University in Durham, NC. He completed his residency in the department of medicine, where he served as chief resident. Dr. Muir also completed fellowships in gastroenterology and health services research at Duke and at the Durham Veterans Administration Medical Center, respectively. He joined the faculty of Duke in the division of gastroenterology.
Dr. Muir is a gastroenterologist whose research activities are focused on developing innovative treatments for a variety of liver diseases. His specific areas of interest include novel therapies for hepatitis C infection, hepatocellular carcinoma, and African-American patient response to hepatitis therapies, as well as racial disparities and issues affecting access to care in hepatitis C treatment and liver transplantation.
Dr. Muir helped to create the site-based research program in gastroenterology at the Duke Clinical Research Institute (DCRI), a program he now leads. He has led successful global clinical trials, including several high-profile studies evaluating new therapeutic approaches in patients with hepatitis C infection. As the research group's capabilities continue to grow, Dr. Muir's efforts are centered on integrating the group's capabilities in developing and testing novel therapies with the overarching mission of the Duke Translational Medicine Institute.
Dr. Muir has a long-standing commitment to improving racial and socioeconomic disparities in health care, as evidenced by his work on health inequalities as a senior research fellow at the Duke Center for Health Policy.
Dr. Muir has authored or co-authored more than 50 peer-reviewed publications. These articles, which have appeared in journals such as Nature, NEJM, Annals of Internal Medicine, Hepatology, and Gastroenterology, include reports evaluating genomics-based strategies for predicting therapeutic response in patients with hepatitis C.
In addition to his achievements as a clinician and researcher, Dr. Muir has also received acclaim for his teaching at Duke, where he has received the Golden Apple Teaching Award, the Eugene A. Stead, Jr. Teaching Award, and the Joseph Greenfield, Jr., MD Mentor Award, among many others.